<DOC>
	<DOCNO>NCT00234949</DOCNO>
	<brief_summary>The purpose study compare efficacy tolerability cefdinir cephalexin patient mild moderate uncomplicated skin/skin structure infection .</brief_summary>
	<brief_title>A Study Compare Cefdinir Cephalexin Treatment Mild Moderate Uncomplicated Skin Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Cefdinir</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<mesh_term>Cephalexin</mesh_term>
	<criteria>Ambulatory male female subject &gt; 13 year old . A female subject must nonlactating risk pregnancy . Diagnosis USSSI 2 follow local sign symptom : Pain/tenderness Swelling Erythema Localized warmth Purulent drainage/discharge Induration Regional lymph node swell tenderness Extension redness Acceptable USSSI include , limited : Cellulitis Erysipelas Impetigo Simple abscess Wound infection Furunculosis Folliculitis A sample microbiologic culture must obtain primary infection site within 48 hour prior study drug administration . Exclusion Criteria Medical history hypersensitivity allergic reaction penicillin and/or cephalosporin ( include cefdinir cephalexin ) antibiotic accord judgment Investigator . Subject complicate skin skin structure infection judge investigator . A chronic underlying skin condition site infection ( e.g. , secondary infect atopic dermatitis eczema ) infection involve prosthetic material ( e.g. , catheter tunnel infection , orthopedic hardware ) . A wound secondary burn injury acne vulgaris . Any infection site require : intraoperative surgical debridement ; excision infect lesion body part . Infections treat surgical incision alone accord judgment Investigator . Any infection necessitates use additional concomitant oral parenteral antibiotic therapy . Known significant renal hepatic impairment indicate : Serum Creatinine &gt; 2.0 mg/dL ( 176.8 mol/L ) SGOT ( AST ) &gt; 3x upper limit reference range SGPT ( ALT ) &gt; 3x upper limit reference range Alkaline Phosphatase &gt; 2x upper limit reference range Total Bilirubin &gt; 2x upper limit reference range Underlying condition and/or disease , accord judgment Investigator , would likely interfere completion course study drug therapy followup . The Investigator considers subject unsuitable candidate cefdinir cephalexin administration</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Cefdinir</keyword>
	<keyword>Cephalexin</keyword>
	<keyword>Skin Infection</keyword>
</DOC>